California becomes first state to ban use of ‘excited delirium’ as cause of death
By Sam Levin and Maanvi Singh,
The Guardian
| 10. 10. 2023
California has become the first state to ban the use of “excited delirium” as a cause of death, prohibiting the pseudoscientific diagnosis that authorities have frequently cited to justify killings at the hands of law enforcement.
Excited delirium – a term rejected by major medical groups, including the American Medical Association – suggests that people can develop “superhuman strength” due to drug use. Medical examiners and coroners have argued that the condition caused victims of brutal police force to struggle and collapse from cardiac arrest, essentially excusing the role of officers who were holding them down, choking or suffocating them.
Governor Gavin Newsom signed a bill on Sunday prohibiting the term from being recognized as valid diagnosis or cause of death. The bill comes as a national emergency physicians’ group is also considering disavowing the term.
The legislation was prompted by the 2020 death of Angelo Quinto, who lost consciousness while two Antioch officers knelt on his neck and back, with the death certificate citing “excited delirium syndrome”. Quinto was suffering a mental health crisis in his mother’s home.
Law...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...